Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009483-03
Application #
2122755
Study Section
Special Emphasis Panel (SRCD)
Project Start
1994-09-30
Project End
1997-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Psychiatry
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Holcomb, Henry H; Lahti, Adrienne C; Medoff, Deborah R et al. (2005) Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology 30:2275-82
Avila, Matthew T; Weiler, Martin A; Lahti, Adrienne C et al. (2002) Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. Am J Psychiatry 159:1490-6
Lahti, A C; Warfel, D; Michaelidis, T et al. (2001) Long-term outcome of patients who receive ketamine during research. Biol Psychiatry 49:869-75
Lahti, A C; Weiler, M A; Tamara Michaelidis, B A et al. (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455-67